About Lucid Genomics
Lucid Genomics is a company based in Berlin (Germany) founded in 2024 by Uira Souto Melo and M-Hossein Moeinzadeh.. Lucid Genomics has raised $1.44 million across 1 funding round from investors including Caesar, BIF Partners and another.vc. Lucid Genomics offers products and services including Lucid Genome Suite and Variant Detection Tool. Lucid Genomics operates in a competitive market with competitors including Natera, Variantyx, Lantern Pharma, LifeCell and Guangzhou Kang Liming Biotechnology, among others.
- Headquarter Berlin, Germany
- Founders Uira Souto Melo, M-Hossein Moeinzadeh
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lucid Genomics Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.44 M (USD)
in 1 rounds
-
Latest Funding Round
$1.44 M (USD), Seed
Sep 04, 2024
-
Investors
Caesar
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lucid Genomics
Lucid Genomics offers a comprehensive portfolio of products and services, including Lucid Genome Suite and Variant Detection Tool. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI platform for detecting and prioritizing genome variants in research.
Software for ranking mutations and reducing false positives in diagnostics.
Funding Insights of Lucid Genomics
Lucid Genomics has successfully raised a total of $1.44M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.44 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.4M
-
First Round
First Round
(04 Sep 2024)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Seed - Lucid Genomics | Valuation | Caesar |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lucid Genomics
Lucid Genomics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Caesar, BIF Partners and another.vc. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A Hamburg-based private investment company focused on VC deals.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital funding is provided to B2B startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lucid Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lucid Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lucid Genomics Comparisons
Competitors of Lucid Genomics
Lucid Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Variantyx, Lantern Pharma, LifeCell and Guangzhou Kang Liming Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| domain | founded_year | HQ Location |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| domain | founded_year | HQ Location |
LifeCell is engaged in cord blood banking services.
|
|
| domain | founded_year | HQ Location |
Cancer detection kits and screening services are provided.
|
|
| domain | founded_year | HQ Location |
Genetic testing for inherited disorders is provided by the company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lucid Genomics
Frequently Asked Questions about Lucid Genomics
When was Lucid Genomics founded?
Lucid Genomics was founded in 2024.
Where is Lucid Genomics located?
Lucid Genomics is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Who is the current CEO of Lucid Genomics?
Uira Souto Melo is the current CEO of Lucid Genomics. They have also founded this company.
Is Lucid Genomics a funded company?
Lucid Genomics is a funded company, having raised a total of $1.44M across 1 funding round to date. The company's 1st funding round was a Seed of $1.44M, raised on Sep 04, 2024.
What does Lucid Genomics do?
Lucid Genomics was founded in 2024 in Berlin, Germany, within the biotechnology and AI sector. An AI-based platform is provided by the company to support analysis of genomic mutations. Detection, interpretation, and prioritization of structural variations across the genome are enabled for healthcare professionals, focusing on those linked to specific genetic diseases. Operations center on tool development for precision medicine applications.
Who are the top competitors of Lucid Genomics?
Lucid Genomics's top competitors include Natera, Lantern Pharma and Nucleus Genomics.
What products or services does Lucid Genomics offer?
Lucid Genomics offers Lucid Genome Suite and Variant Detection Tool.
Who are Lucid Genomics's investors?
Lucid Genomics has 4 investors. Key investors include Caesar, BIF Partners, another.vc, and Max-Planck-Förderstiftung.